Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Effects of Chemicals: Overview

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...

Chemical Shift: Internal References and Solvent Effects

Chemical Shift: Internal References and Solvent Effects

In an NMR sample, precise measurement of the absolute absorption frequencies of nuclei is difficult. A standard internal reference compound is added, and the frequency difference between the reference signal and sample signals is measured.
The internal reference compound generally used in NMR spectroscopy is tetramethylsilane (TMS). TMS is preferred because it is chemically inert, soluble in NMR solvents, and easily removable. Also, the highly shielded methyl protons in TMS yield an intense...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incorporation and Repair of Epigenetic Intermediates as Potential Chemotherapy Agents.

Molecules (Basel, Switzerland)·2025

Same author

Hypothesis-driven weight of evidence evaluation indicates ethylbenzene lacks endocrine disruption potential by EATS pathways.

EXCLI journal·2025

Same author

Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathways.

Archives of toxicology·2025

Same author

Kinetically-derived maximal dose (KMD) confirms lack of human relevance for high-dose effects of octamethylcyclotetrasiloxane (D4).

Archives of toxicology·2025

Same author

The physiological and biochemical basis of potency thresholds modeled using human estrogen receptor alpha: implications for identifying endocrine disruptors.

Archives of toxicology·2024

Same author

Kinetically-derived maximal dose (KMD) indicates lack of human carcinogenicity of ethylbenzene.

Archives of toxicology·2023

Search research articles

Related Experiment Video

Updated: May 16, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Data disclosure for chemical evaluations.

Randall Lutter¹, Craig Barrow, Christopher J Borgert

¹Independent Consultant, Bethesda, Maryland, USA. rwlutter@gmail.com

Environmental Health Perspectives

|December 12, 2012

Summary

This summary is machine-generated.

Public disclosure of scientific data used by the U.S. Environmental Protection Agency (EPA) enhances confidence in chemical regulations. The EPA should provide raw data and methods for independent reanalysis to ensure transparency and reliability.

More Related Videos

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Published on: February 23, 2020

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Related Experiment Videos

Last Updated: May 16, 2026

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface

Published on: February 23, 2020

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Area of Science:

Environmental Science
Chemical Regulation
Data Transparency

Background:

Public trust in government regulatory decisions on chemicals hinges on data transparency.
Disclosure of scientific data strengthens the foundation of regulatory science.

Purpose of the Study:

To review the U.S. Environmental Protection Agency's (EPA) current data disclosure practices for chemical and pesticide regulations.
To identify opportunities for enhanced data accessibility and transparency in regulatory decision-making.

Main Methods:

Review of U.S. EPA's existing policies and practices for chemical data disclosure.
Analysis of opportunities to promote broader access to scientific data used in regulatory decisions.

Main Results:

Current U.S. EPA practices for data disclosure were examined.
Opportunities for improving transparency and data accessibility were identified.

Conclusions:

The U.S. EPA should provide underlying raw data and methods for scientific research used in regulatory decisions to enable independent reanalysis.
Transparency in data and methods, including sensitivity analyses, is crucial for validating regulatory determinations.
If full data access is not possible, the U.S. EPA must disclose the extent of its access to ensure accountability.